Cited by 143Adrenal and Paraganglionic TumorsNeuroendocrine Tumor Research AdvancesHormonal Regulation and Hypertension

Pheochromocytoma

Open access
Manger, William M., Gifford, Ray W.·2002·The Journal of Clinical Hypertension

Abstract

Pheochromocytoma, a relatively rare (<0.05% of hypertensives), catecholamine-secreting tumor, is almost always lethal unless recognized and appropriately treated. Clinical and biochemical manifestations are mainly caused by excess circulating catecholamines and hypertension. Manifestations mimic many conditions, which may result in erroneous diagnoses and improper treatment. Sustained or paroxysmal hypertension associated with headaches, sweating, or palpitations, occurs in 95% of patients, but at least 5% are normotensive. All patients with manifestations of hypercatecholaminemia or coexisting neoplasms should be investigated for pheochromocytoma. Plasma free metanephrines and fractionated urinary metanephrines are the most sensitive (about 100%) chemical tests for diagnosing sporadic and familial pheochromocytomas; plasma and urinary catecholamines and total metanephrines are fairly sensitive for identifying sporadic cases but are less sensitive for familial tumors. The clonidine suppression test helps exclude other conditions that may elevate plasma and urinary catecholamines and their metabolites. Magnetic resonance imaging is more sensitive than computed tomography for localizing pheochromocytomas; iodine-131-metaiodobenzylguanidine (131I-MIBG) tumor uptake confers specificity. Surgical resection is successful in 90% of cases, but 10% of tumors are malignant. Pheochromocytomas <5 cm in diameter can be removed laparoscopically; larger tumors should be removed by open surgery. Drug treatment prior to and during surgery is mandatory; drug treatment, chemotherapy, and radiation therapy are used to treat malignant lesions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1524-6175.2002.01452.x

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hypertension is a common sign of pheochromocytoma, but 5% to 15% of patients may have normal blood pressure at presentation, particularly those with incidentaloma or familial screening.

    “Hypertension is a common sign of pheochromocytoma, but 5% to 15% of patients may have normal blood pressure at presentation, particularly in those with incidentaloma or having familial screening where the tumor may be smaller and less functionally active at presentation (190).”

    From Adrenal incidentaloma (2020) · cites this paper as [190]

  • Headache occurs in up to 90% of symptomatic patients with pheochromocytoma, with sweating in 60% to 70%.

    “Headache occurs in up to 90% of symptomatic patients (190) with sweating in 60% to 70%.”

    From Adrenal incidentaloma (2020) · cites this paper as [190]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Manger, W. M., & Gifford, R. W.
Affiliations
Cleveland Clinic (US)
Corresponding author
Manger, William M.
Venue
The Journal of Clinical Hypertension
Publisher
Wiley
Published
2002-01
Volume
4
Issue
1
Pages
62-72
ISSN
  • 1524-6175 (ISSN-L)
  • 1751-7176
OpenAlex
W3188240819
Cited by
143
References
40
Citations by year
2026: 6 · 2025: 2 · 2024: 10 · 2023: 10 · 2022: 14 · 2021: 11 · 2020: 6 · 2019: 2 · 2018: 6 · 2017: 4 · 2016: 3 · 2015: 8 · 2014: 7 · 2013: 5 · 2012: 4
FWCI
1.24
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Hypertension (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords
pheochromocytoma, catecholamine-secreting tumors, hypertension, hypercatecholaminemia, metanephrine, clonidine suppression test, 131I-MIBG scintigraphy, magnetic resonance imaging, laparoscopic resection, malignant pheochromocytoma, familial pheochromocytoma
MeSH terms
Adrenal Gland Neoplasms, Algorithms, Diagnosis, Differential, Humans, Hypertension, Pheochromocytoma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review